Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Summit 2013 + Expo
HLA-DRB1*15:01 and multiple sclerosis: a female association?
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
Scientific discussion for the approval of Masivet
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.
T(H)17 cytokines in autoimmune neuro-inflammation.
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Sex ratio of multiple sclerosis and clinical phenotype.
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
[Recommendations for a brief international cognitive assessment for multiple sclerosis].
Temporal trends in the incidence of multiple sclerosis: a systematic review.
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
ECTRIMS 2015
Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
Heartbleed Bug
Transfer of interferon β-1a into human breastmilk.
Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Cooperative Meeting with Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Seeing illness in art and medicine: a patient and printmaker collaboration.
MS Research Roundup: January 29, 2014
Demyelination of the hippocampus is prominent in the cuprizone model.
Episode 38 with Dr. Joseph Berger on progressive multifocal leukoencephalopathy
The natural history of primary progressive MS in British Columbia, Canada.

Pages